Member Login
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (NYSE: BHC)
    3. /

NYSE:BHC (Bausch Health Companies Inc.)

About BHC

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (NYSE: BHC) Latest News

    The Motley Fool
    Investing

    Was Bill Ackman Wrong to Sell His Stake in Valeant Pharmaceutical Intl Inc.?

    | Joey Frenette

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) soared 24.1% in a single trading session following an upgraded forecast. Is it time to…

    Read more »

    The Motley Fool
    Investing

    1 Beaten-Up Stock With a Potential 50% Upside

    | Chris MacDonald

    Here's my take on why Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is currently undervalued by approximately 50%.

    Read more »

    Investing

    What Canopy Growth Corp can Learn From Valeant Pharmaceuticals Intl Inc

    | Ryan Goldsman

    After egregious destruction of shareholder wealth, Valeant Pharmaceuticals Intl Inc (TSX:VRX)(NYSE:VRX) will hopefully be a learning opportunity for Canopy Growth…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Is a Recovery Possible?

    | Demetris Afxentiou

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has to address a growing number of long-standing issues before it can be considered a…

    Read more »

    The Motley Fool
    Investing

    How Much Longer Should You Hold Shares of Valeant Pharmaceuticals Intl Inc.?

    | Ryan Goldsman

    Bill Ackman is walking away from Valeant Pharmaceuticals Intl Inc (TSX:VRX)(NYSE:VRX). Should you?

    Read more »

    The Motley Fool
    Investing

    Could Valeant Pharmaceuticals Intl Inc. Go to $0?

    | Joey Frenette

    Many pundits believe Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) could be on its way to bankruptcy. Should you be worried?

    Read more »

    caution
    Investing

    Bombardier, Inc.: Gold-Plated Compensation But Not Much Else

    | Will Ashworth

    The news is out on Bombardier, Inc. (TSX:BBD.B) compensation. It turns out, corporate welfare pays handsomely, despite very little to…

    Read more »

    The Motley Fool
    Investing

    With Ackman Gone, Has Valeant Pharmaceuticals Intl Inc. Hit Rock Bottom?

    | Chris MacDonald

    Is now the time to dump Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) like Bill Ackman, or is it time take a…

    Read more »

    Investing

    Is Valeant Pharmaceuticals Intl Inc. Canada’s Cheapest Stock?

    | Nelson Smith

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) trades at just two times trailing free cash flow. But that doesn't tell the whole…

    Read more »

    caution
    Investing

    Why You Shouldn’t Own Valeant Pharmaceuticals Intl Inc.

    | Will Ashworth

    The latest news from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is proof that Bill Ackman was wise to get out.

    Read more »

    The Motley Fool
    Investing

    Investors: Forget Valeant Pharmaceuticals Intl Inc.: Check Out CRH Medical Corp. Instead

    | Karen Thomas, MSc, CFA

    Invest in CRH Medical Corp. (TSX:CRH) for exposure to a growing and profitable healthcare company.

    Read more »

    The Motley Fool
    Investing

    What We Can Learn From Bill Ackman Walking Away From Valeant Pharmaceuticals Intl Inc.

    | Ryan Goldsman

    Investors can learn a lot from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »